[Nimesulide: a lower risk treatment in rheumatic diseases].


This review paper presents some basic information of a "rediscovered" nonsteroidal anti-inflammatory drug Nimesulid which is one of the first selective inhibitors of cyclooxygenase-2, has a history of good clinical results, and is relatively well tolerated with patients. Nimesulid enhances possible ways of analgesia treatment of rheumatic diseases. 


Cite this paper

@article{Trnavsk2004NimesulideAL, title={[Nimesulide: a lower risk treatment in rheumatic diseases].}, author={Karel Trnavsk{\'y}}, journal={Vnitrni lekarstvi}, year={2004}, volume={50 2}, pages={157-62} }